i2Contour

by MRIMath LLC  · Based in United States → — Empowering Faster, More Confident Treatment Decisions
Neurosurgery Oncology Radiology

Regulatory Status Disclosed

Overview

i2Contour is a web-based, AI-powered software platform developed by MRIMath. It is specifically designed to enhance the efficiency and precision of glioblastoma (GBM) management. The tool provides semi-automatic labeling, visualization, and volumetric quantification of WHO grade 4 glioblastoma from standard MRI images, including FLAIR and T1 contrast sequences. It combines advanced AI algorithms with a user-friendly interface, allowing trained medical professionals to review, manually contour, and approve tumor segmentations. The platform aims to significantly reduce the time required for GBM labeling and volume measurement, potentially saving physicians up to an hour per imaging study. By minimizing inter-user variability and improving precision, i2Contour supports better clinical decision-making, treatment planning, and monitoring of patient outcomes over time.

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Key Features

  • AI-powered GBM segmentation (FLAIR and T1 contrast sequences)
  • Smart manual contouring to reduce inter-user variability
  • Precise volume measurement and plotting for monitoring and treatment planning
  • Time-saving efficiency (reduces labeling/measurement time by up to an hour)
  • Secure cyber device compliant with FDA security measures
  • Collaborative team spaces for workflow optimization
  • DICOM viewer
  • Web-based software platform
  • Anonymization of patient data
  • Sharing and exchange capabilities

Use Cases

  • Glioblastoma (GBM) management
  • Brain tumor segmentation and volumetric analysis
  • Radiation therapy planning
  • Monitoring treatment response over time for GBM
  • Aiding clinical decision-making in neuro-oncology
  • Collaborative review and approval processes for imaging studies

What Physicians Need to Know

Key Capabilities
AI-based and smart manual segmentation for GBM and metastatic brain tumors, organs-at-risk segmentation, uncertainty quantification, GBM volumetric measurements/plots, and a GBM DICOM viewer. It also offers secure communications, registration, sharing/exchange, and anonymization.
Clinical Utility
Empowers faster, more confident treatment decisions for GBM care by providing accurate measurements of brain tumor volume. It enhances the ability of radiologists and neuro-oncologists to monitor patients over time, facilitating early detection of tumor progression and recurrence. It aims to improve quality and advance patient care while potentially lowering healthcare costs.
Integration Options
The platform is designed to seamlessly integrate into clinical workflows. It offers a secure, HIPAA-compliant cloud environment for collaboration and data exchange.
Compliance Status
FDA 510k-Cleared Cyber Device and AI Solution for GBM Care. MRIMath has achieved ISO 13485 Certification. It offers HIPAA-compliant cloud storage.
User Experience
Described as exceptionally user-friendly and easy to use for manual contouring, with an intuitive design for reviewing and revising segmented tumors. It aims for the least number of clicks to generate helpful information.
Implementation Complexity
Described as easy to learn and seamlessly integrates into workflows.
Evidence Base
MRIMath publishes in Neuro-Oncology Advances, including AI LGG Growth Assessment.
Physician Tip

Leverage i2Contour's FDA 510k-cleared AI for rapid and accurate GBM and metastatic brain tumor segmentation to enhance treatment decision-making and patient monitoring. Utilize the secure, cloud-based platform for collaborative research and consultations, and take advantage of the volumetric measurements for longitudinal tracking of disease progression or response to treatment. The smart manual contouring and AI-powered features can significantly reduce contouring time and inter-user variability.

The platform is cloud-based and designed for secure communication and data exchange, facilitating collaboration among healthcare professionals. It supports the download of segmentations and volumes, and offers registration, sharing, and anonymization features for seamless integration into existing clinical and research workflows.

Details

Category Oncology AI, Radiology & Imaging AI
Pricing Unknown
Free Trial Yes
DeploymentCloud-based
Data Export Yes
Compliance
BAA Available Yes AI-estimated
HIPAA Compliant Yes AI-estimated
FDA Status Yes AI-estimated
Integrations
EHR Not specified
Specialties Neurosurgery, Oncology, Radiology

FDA clearance history

This product’s FDA authorization. From FDA’s list of AI-enabled medical devices; each number links to FDA’s record.

Decision dateNumberName as listed by FDA
2024-08-08K233822 510(k)i2Contour

Ratings & Reviews

No reviews yet. Be the first to review this tool!

Rate i2Contour

Clinical Value
Ease of Use
Integration
Support & Docs
Value for Money
No press coverage or publications on file yet. Know of some? Suggest an edit →

Videos

Product demos, reviews, and walkthroughs for i2Contour.

Loading videos...

View all on YouTube

Frequently Asked Questions

i2Contour, as part of the MRIMath platform, offers AI-based and semi-automated contouring capabilities for neoplasms on FLAIR and T1C sequences. This allows for accurate measurement of disease volume, which helps radiologists and neuro-oncologists monitor patients over time and detect tumor progression or recurrence.
The MRIMath platform includes an FDA 510k-Cleared Cyber Device and AI Solution for GBM Care. This clearance applies to the cyber device and AI solution for Glioblastoma (GBM) management.
The provided text does not explicitly detail specific limitations of i2Contour for tumor segmentation. However, it emphasizes its utility in providing accurate measurements and streamlining workflows for GBM and other brain tumors.
The MRIMath platform, which includes i2Contour features, offers a secure, HIPAA-compliant cloud environment. This enables physicians to work from anywhere, store data securely, and ensures sensitive information is handled safely.
Yes, in addition to AI-based segmentation, the MRIMath platform also offers 'Smart Manual Segmentation'. This provides physicians with options for contouring based on their preference or specific clinical needs.
Yes, the MRIMath platform includes 'Organs at Risk Segmentation' as one of its AI-powered segmentation capabilities. This feature assists in accurately contouring critical structures near tumors.

Related Tools

VERITON CT 400 Series Digital SPECT/CT System (VERITON CT 416/464)
Spectrum Dynamics Medical
Oncology AI
The VERITON CT 400 Series is a digital SPECT/CT system with a 360-degree gantry and 12 swiveling CZT detectors, offering high sensitivity and quantitative accuracy for a wide range of nuclear medicine applications, including advanced theranostics imaging.
syngo.via MI Workflows, syngo MBF
Siemens Medical Solutions USA
Cardiology AI
syngo.via MI Workflows, syngo MBF is an intelligent, integrated imaging software that helps address the challenges of interpreting, managing, and sharing complex data from molecular imaging scanners, providing automated workflows and advanced visualization for various clinical applications.
syngo.via MI WorkFlows, Scenium, syngo MBF
Siemens Medical Solutions USA
Cardiology AI
syngo.via MI Workflows, Scenium, and syngo MBF are medical diagnostic post-processing applications for viewing, manipulation, quantification, analysis, and comparison of PET or nuclear-medicine functional data with CT or MR anatomical data across timepoints, supporting disease management and radiotherapy treatment planning by trained healthcare professionals.
BIOGRAPH One
Siemens Healthineers AG
Oncology AI
BIOGRAPH One is a second-generation PET/MR scanner designed to transform PET/MR image quality for a new era, combining high PET precision with powerful MR performance. It enables simultaneous visualization of organ location, function, and cellular metabolism, offering faster image acquisition times and more efficient workflows than previous generations of PET/MR scanners.
Claire™ OCT System
Perimeter Medical Imaging AI
Oncology AI
Perimeter Medical Imaging AI is a medical technology company driven to transform cancer surgery with ultra-high resolution, real-time, advanced imaging tools that address unmet medical needs.S. for intraoperative breast cancer margin assessment.
syngo.via RT Image Suite VC10
Varian Medical Systems, Inc.
Clinical Decision Support & Reference
syngo.via RT Image Suite VC10 offers advanced imaging and workflow solutions for precise and efficient radiation therapy planning.

See all Oncology AI tools →

Suggest an Edit → | Report an issue | Last Verified: 2026-11-17 | First Added: 2026-04-20
AI Tool Finder
AI-powered search. Results may not be comprehensive.